Camilo Jimenez

Camilo Jimenez

UNVERIFIED PROFILE

Are you Camilo Jimenez?   Register this Author

Register author
Camilo Jimenez

Camilo Jimenez

Publications by authors named "Camilo Jimenez"

Are you Camilo Jimenez?   Register this Author

98Publications

1472Reads

44Profile Views

Genetic profiling as a clinical tool in advanced parathyroid carcinoma.

J Cancer Res Clin Oncol 2019 Aug 15;145(8):1977-1986. Epub 2019 Jul 15.

Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street Unit 1461, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-019-02945-9DOI Listing
August 2019

Recent advances in the management of malignant pheochromocytoma and paraganglioma: focus on tyrosine kinase and hypoxia-inducible factor inhibitors.

F1000Res 2018 30;7. Epub 2018 Jul 30.

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12688/f1000research.13995.1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069727PMC
July 2019

Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond.

Endocr Rev 2019 Jul 19. Epub 2019 Jul 19.

Department of Endocrine Neoplasia & Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/er.2019-00007DOI Listing
July 2019

Targeted Radionuclide Therapy for Patients with Metastatic Pheochromocytoma and Paraganglioma: From Low-Specific-Activity to High-Specific-Activity Iodine-131 Metaiodobenzylguanidine.

Cancers (Basel) 2019 Jul 20;11(7). Epub 2019 Jul 20.

Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11071018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678905PMC
July 2019

Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study.

Lancet Diabetes Endocrinol 2019 Mar 16;7(3):213-220. Epub 2019 Jan 16.

Endocrine Oncology, Institut Gustave Roussy Ecole Doctorale de Cancerologie, Villejuif, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22138587183033
Publisher Site
http://dx.doi.org/10.1016/S2213-8587(18)30336-XDOI Listing
March 2019

Treatment for Patients With Malignant Pheochromocytomas and Paragangliomas: A Perspective From the Hallmarks of Cancer.

Authors:
Camilo Jimenez

Front Endocrinol (Lausanne) 2018 28;9:277. Epub 2018 May 28.

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fendo.2018.00277DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985332PMC
May 2018

Calcitriol-mediated hypercalcemia secondary to granulomatous disease caused by soft-tissue filler injection: a case report.

Clin Cases Miner Bone Metab 2017 Sep-Dec;14(3):340-346. Epub 2017 Dec 27.

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.11138/ccmbm/2017.14.3.340DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762227PMC
December 2017

Treatment for Malignant Pheochromocytomas and Paragangliomas: 5 Years of Progress.

Curr Oncol Rep 2017 Oct 28;19(12):83. Epub 2017 Oct 28.

Department of Endocrine Neoplasia and Hormonal Disorders, Unit 1461, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-017-0643-0DOI Listing
October 2017

Phase II trial of pazopanib in advanced/progressive malignant pheochromocytoma and paraganglioma.

Endocrine 2017 Aug 6;57(2):220-225. Epub 2017 Jul 6.

Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12020-017-1359-5DOI Listing
August 2017

Malignant pheochromocytoma-paraganglioma: pathogenesis, TNM staging, and current clinical trials.

Curr Opin Endocrinol Diabetes Obes 2017 Jun;24(3):174-183

aDepartment of Endocrinology, Hospital Universitario San Vicente Fundacion-Universidad de Antioquia, Medellín, Colombia bDepartment of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MED.0000000000000330DOI Listing
June 2017

Effectiveness of first-line pegvisomant monotherapy in acromegaly: an ACROSTUDY analysis.

Eur J Endocrinol 2017 Feb 15;176(2):213-220. Epub 2016 Nov 15.

Neuroendocrine UnitMassachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/EJE-16-0697DOI Listing
February 2017

Bone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma.

J Clin Endocrinol Metab 2016 12 23;101(12):4871-4877. Epub 2016 Sep 23.

Departments of Endocrine Neoplasia and Hormonal Disorders (J.Y.X., C.J., S.N.R., M.A.H., S.G.W., R.D., R.F.G., A.K.Y., M.E.C., S.P.W., N.L.B., R.V.S., S.I.S., M.I.H.), Radiology (W.A.M.), Biostatistics (D.R.M.), and Endocrine Surgery (E.G.), University of Texas MD Anderson Cancer Center, Houston, Texas 77230-1402.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2016-2815DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155685PMC
December 2016

Medullary Thyroid Carcinoma Associated with Germline RET Mutation.

Thyroid 2016 12 18;26(12):1744-1751. Epub 2016 Oct 18.

1 Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center , Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/thy.2016.0374DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175438PMC
December 2016

Detection and Prognostic Significance of Circulating Tumor Cells in Patients With Metastatic Thyroid Cancer.

J Clin Endocrinol Metab 2016 11 30;101(11):4461-4467. Epub 2016 Aug 30.

Department of Endocrine Neoplasia and Hormonal Disorders (J.Y.X., C.L.M., S.G.W., M.I.H., N.B., C.J., M.E.C., G.J.C., S.I.S.), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030; and Laboratory Medicine (B.H., H.A.F.), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2016-2567DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095245PMC
November 2016

Preexisting adrenal masses in patients with adrenocortical carcinoma: clinical and radiological factors contributing to delayed diagnosis.

Endocrine 2016 Feb 25;51(2):351-9. Epub 2015 Jul 25.

Department of Endocrine Neoplasia and Hormonal Disorders, Unit 1461, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12020-015-0694-7DOI Listing
February 2016

Pheochromocytoma in Urologic Practice.

Eur Urol Focus 2016 Feb 28;1(3):231-240. Epub 2016 Sep 28.

Fox Chase Cancer Center, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euf.2015.09.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222610PMC
February 2016

Metastatic sympathetic paraganglioma in a patient with loss of the SDHC gene.

Fam Cancer 2015 Dec 11;14(4):615-9. Epub 2015 Jul 11.

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street Unit 1461, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10689-015-9821-0DOI Listing
December 2015

Constipation: an overlooked, unmanaged symptom of patients with pheochromocytoma and sympathetic paraganglioma.

Eur J Endocrinol 2015 Sep 9;173(3):377-87. Epub 2015 Jun 9.

Department of Endocrine Neoplasia and Hormonal DisordersThe University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1461, Houston, Texas 77030, USADepartment of EndocrinologyHospital San Vicente Fundacion-Universidad de Antioquia, Medellin, ColombiaDepartment of BiostatisticsThe University of Texas MD Anderson Cancer Center, Houston, Texas, USADepartment of GastroenterologyHepatology and Nutrition, The University of Texas Health Science Center at Houston, Houston, Texas, USAIndependent Nurse Consultantretired from The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/EJE-15-0456DOI Listing
September 2015

Functional imaging for pheochromocytoma-paraganglioma: a step closer to understanding its place in clinical practice.

Endocrine 2015 Sep 26;50(1):6-8. Epub 2015 Jun 26.

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12020-015-0672-0DOI Listing
September 2015

Succinate dehydrogenase gene mutations in cardiac paragangliomas.

Am J Cardiol 2015 Jun 24;115(12):1753-9. Epub 2015 Mar 24.

Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2015.03.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450109PMC
June 2015

Efficacy and tolerability of vemurafenib in patients with BRAF(V600E) -positive papillary thyroid cancer: M.D. Anderson Cancer Center off label experience.

J Clin Endocrinol Metab 2015 Jan;100(1):E77-81

Departments of Endocrine Neoplasia and Hormonal Disorders (R.D., N.L.B., S.G.W., M.A.H., A.K.Y., M.I.H., C.J., S.I.S., M.E.C.), Diagnostic Radiology (K.S.), and Biostatistics (R.B.), The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2014-2246DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283003PMC
January 2015

Medullary thyroid cancer in the era of tyrosine kinase inhibitors: to treat or not to treat--and with which drug--those are the questions.

J Clin Endocrinol Metab 2014 Dec;99(12):4390-6

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2014-2811DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255127PMC
December 2014

Clinical and radiologic features of pheochromocytoma/ganglioneuroma composite tumors: a case series with comparative analysis.

Endocr Pract 2014 Sep;20(9):864-9

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://journals.aace.com/doi/abs/10.4158/EP14010.OR
Publisher Site
http://dx.doi.org/10.4158/EP14010.ORDOI Listing
September 2014

Therapy of endocrine disease: treatment of malignant pheochromocytoma and paraganglioma.

Eur J Endocrinol 2014 Sep 2;171(3):R111-22. Epub 2014 Jun 2.

Département de Médecine Nucléaire et de Cancérologie EndocrinienneRadiologie Interventionnelle, Chirurgie, Imagerie, Institut Gustave Roussy, Université Paris Sud, 114 Rue Edouard Vaillant 94805 villejuif Cedex, Paris, France andDepartment of Endocrine Neoplasia and Hormone DisordersUnit 1461, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, Texas 77030, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/EJE-14-0113DOI Listing
September 2014

Role of salvage targeted therapy in differentiated thyroid cancer patients who failed first-line sorafenib.

J Clin Endocrinol Metab 2014 Jun 14;99(6):2086-94. Epub 2014 Mar 14.

Departments of Endocrine Neoplasia and Hormonal Disorders (R.D., S.G.W., N.L.B., M.I.H., C.J., M.A.H., R.V.S., A.K.Y., G.J.C., S.I.S., M.E.C.), Diagnostic Radiology (C.D.), and Biostatistics (M.H.), The University of Texas M. D. Anderson Cancer Center; and Department of Endocrinology, Diabetes, and Metabolism (R.D.), Baylor College of Medicine, Houston, Texas 77030.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2013-3588DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037722PMC
June 2014

Update on medullary thyroid cancer.

Endocrinol Metab Clin North Am 2014 Jun;43(2):423-42

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1461, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ecl.2014.02.004DOI Listing
June 2014

Efficacy and tolerability of different starting doses of sorafenib in patients with differentiated thyroid cancer.

Oncologist 2014 May 14;19(5):477-82. Epub 2014 Apr 14.

Departments of Endocrine Neoplasia and Hormonal Disorders and Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Endocrinology, Diabetes and Metabolism, Baylor College of Medicine, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2013-0409DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012968PMC
May 2014

Adrenal ganglioneuroma: features and outcomes of 27 cases at a referral cancer centre.

Clin Endocrinol (Oxf) 2014 Mar 18;80(3):342-7. Epub 2013 Sep 18.

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cen.12320DOI Listing
March 2014

Impact of surgical resection for subdiaphragmatic paragangliomas.

World J Surg 2014 Mar;38(3):733-41

Department of Surgical Oncology, Unit 1484, The University of Texas MD Anderson Cancer Center, P.O. Box 301402, Houston, TX, 77230-1402, USA,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00268-013-2443-5
Publisher Site
http://dx.doi.org/10.1007/s00268-013-2443-5DOI Listing
March 2014

Treating medullary thyroid cancer in the age of targeted therapy.

Int J Endocr Oncol 2014;1(2):203-216

Department of Endocrine Neoplasia & Hormonal Disorders, Unit 1461, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/ije.14.26DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405124PMC
January 2014

Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center.

Eur J Endocrinol 2013 Dec 23;169(6):891-899. Epub 2013 Oct 23.

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center (UTMDACC), Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/EJE-13-0519DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441210PMC
December 2013

A miRNA signature associated with human metastatic medullary thyroid carcinoma.

Endocr Relat Cancer 2013 Dec 14;20(6):809-23. Epub 2013 Oct 14.

Departments of Endocrine Neoplasia and Hormonal Disorders Experimental Therapeutics Urology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA Department of Oncology, The University of Naples, Naples, Italy Department of Pathology, Centro Oncologico Fiorentino, Sesto Fiorentino, Florence, Italy Verna and Marrs McLean Department of Biochemistry and Molecular Biology Baylor College of Medicine, Houston, Texas, USA Department of Oncology, Istituto Toscano Tumori, Hospital of Prato, Prato, Italy Department of Gynecologic Oncology, Center for RNA Interference and Non-coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Department of Endocrinology, University of Messina, Messina, Italy Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA Department of Internal Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-13-0357DOI Listing
December 2013

Mitotane-induced hyperlipidemia: a retrospective cohort study.

Int J Endocrinol 2013 14;2013:624962. Epub 2013 Nov 14.

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://downloads.hindawi.com/journals/ije/2013/624962.pdf
Web Search
http://www.hindawi.com/journals/ije/2013/624962/
Publisher Site
http://dx.doi.org/10.1155/2013/624962DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848058PMC
December 2013

The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2.

J Clin Endocrinol Metab 2013 Nov 12;98(11):E1813-9. Epub 2013 Sep 12.

MD, AssociateDepartment of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street Unit 1461, Houston, TX 77030.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2013-1653DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399523PMC
November 2013

Current and future treatments for malignant pheochromocytoma and sympathetic paraganglioma.

Curr Oncol Rep 2013 Aug;15(4):356-71

Department of Endocrine Neoplasia and Hormonal Disorders, Unit 1461, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-013-0320-xDOI Listing
August 2013

Genetic testing in head and neck paraganglioma: who, what, and why?

J Neurol Surg B Skull Base 2013 Aug 12;74(4):236-40. Epub 2013 Apr 12.

Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0033-1342924
Publisher Site
http://dx.doi.org/10.1055/s-0033-1342924DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3715610PMC
August 2013

Bone metastases and skeletal-related events in patients with malignant pheochromocytoma and sympathetic paraganglioma.

J Clin Endocrinol Metab 2013 Apr 22;98(4):1492-7. Epub 2013 Feb 22.

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2012-4231DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393459PMC
April 2013

Reduced risk of colorectal cancer with use of oral bisphosphonates: a systematic review and meta-analysis.

J Clin Oncol 2013 Feb 26;31(5):623-30. Epub 2012 Dec 26.

The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.42.9530DOI Listing
February 2013

Long-term outcomes of surgical treatment for hereditary pheochromocytoma.

J Am Coll Surg 2013 Feb;216(2):280-9

Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030-4008, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jamcollsurg.2012.10.012DOI Listing
February 2013

Greater than age-predicted functional deficits in older patients with primary hyperparathyroidism.

Endocr Pract 2012 Jul-Aug;18(4):450-5

Department of Rehabilitation Services, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4158/EP11206.ORDOI Listing
January 2013

A retrospective cohort analysis of the efficacy of adjuvant radiotherapy after primary surgical resection in patients with adrenocortical carcinoma.

J Clin Endocrinol Metab 2013 Jan 12;98(1):192-7. Epub 2012 Nov 12.

Department of Endocrine Neoplasia and Hormonal Disorders, Unit 1461, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2012-2367DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3537094PMC
January 2013

The noninvestigational use of tyrosine kinase inhibitors in thyroid cancer: establishing a standard for patient safety and monitoring.

J Clin Endocrinol Metab 2013 Jan 26;98(1):31-42. Epub 2012 Nov 26.

Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Baylor College of Medicine, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2012-2909DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3537108PMC
January 2013

Robotic-assisted retroperitoneoscopic adrenalectomy: making a good procedure even better.

Am Surg 2013 Jan;79(1):84-9

Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
January 2013

Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas.

J Clin Endocrinol Metab 2012 Nov 10;97(11):4040-50. Epub 2012 Sep 10.

Department of Endocrine Neoplasia and Hormonal Disorders, Unit 1461, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
https://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.
Publisher Site
http://dx.doi.org/10.1210/jc.2012-2356DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3683800PMC
November 2012

Preoperative serum osteocalcin may predict postoperative elevated parathyroid hormone in patients with primary hyperparathyroidism.

World J Surg 2012 Jun;36(6):1320-6

Department of Family and Community Medicine, University of Texas Medical School at Houston, 6431 Fannin Street #JJL324, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00268-012-1432-4DOI Listing
June 2012

A novel SDHB mutation associated with hereditary head and neck paraganglioma.

Laryngoscope 2011 Dec;121(12):2572-5

Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/lary.22352DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420815PMC
December 2011

Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: the University of Texas MD Anderson Cancer Center Experience.

Cancer 2011 Oct 15;117(19):4381-9. Epub 2011 Mar 15.

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.26029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3134535PMC
October 2011

Opioid-induced biochemical alterations of the neuroendocrine axis.

Expert Rev Endocrinol Metab 2011 Sep;6(5):705-713

a Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/eem.11.55DOI Listing
September 2011

Management of medullary thyroid carcinoma and MEN2 syndromes in childhood.

Nat Rev Endocrinol 2011 Aug 23;7(10):596-607. Epub 2011 Aug 23.

The Department of Endocrine Neoplasia and Hormonal Disorders, PO Box 301402, Unit 1461, Houston, TX 77230-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrendo.2011.139DOI Listing
August 2011

Medullary thyroid carcinoma: molecular signaling pathways and emerging therapies.

J Thyroid Res 2011 16;2011:815826. Epub 2011 May 16.

Department of Endocrinology, Hospital San Juan de Dios, Avenida 14, Calles 6 Y 7 Paseo Colon, 1475-1000 San José, Costa Rica.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4061/2011/815826DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112527PMC
July 2011

Novel germline SDHD mutation: diagnosis and implications to the patient.

Fam Cancer 2011 Jun;10(2):365-71

Departments of Endocrine Neoplasia and Hormonal Disorders, Unit 1461, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10689-011-9421-6
Publisher Site
http://dx.doi.org/10.1007/s10689-011-9421-6DOI Listing
June 2011

Benign familial hypocalciuric hypercalcemia.

Endocr Pract 2011 Mar-Apr;17 Suppl 1:13-7

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4158/EP10308.RADOI Listing
June 2011

Posterior retroperitoneoscopic adrenalectomy: a contemporary American experience.

J Am Coll Surg 2011 Apr;212(4):659-65; discussion 665-7

Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jamcollsurg.2010.12.023DOI Listing
April 2011

Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators.

J Clin Endocrinol Metab 2011 Mar 29;96(3):717-25. Epub 2010 Dec 29.

Department of Endocrine Neoplasia and Hormonal Disorders, Unit 1461, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2010-1946DOI Listing
March 2011

A catecholamine crisis on Mount Kilimanjaro: a hypoxia effect?

J Travel Med 2010 Nov-Dec;17(6):424-6

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1708-8305.2010.00463.xDOI Listing
February 2011

Succinate dehydrogenase gene mutations are strongly associated with paraganglioma of the organ of Zuckerkandl.

Endocr Relat Cancer 2010 Sep 3;17(3):581-8. Epub 2010 Jun 3.

Section on Endocrinology and Genetics and Pediatric Endocrinology Program, Program on Developmental Endocrinology and Genetics (PDEGEN), National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Building 10, CRC, 10 Center Drive, Room 1-3330, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1677/ERC-10-0004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417306PMC
September 2010

Malignant head and neck paragangliomas: is there an optimal treatment strategy?

Head Neck Oncol 2010 Sep 23;2:23. Epub 2010 Sep 23.

Scott Department of Urology, Baylor College of Medicine, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1758-3284-2-23DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956716PMC
September 2010

Paraganglioma syndrome type 1 in a patient with Carney-Stratakis syndrome.

Nat Rev Endocrinol 2010 Feb;6(2):110-5

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1461, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrendo.2009.250DOI Listing
February 2010

Fatal hypoglycemia in malignant pheochromocytoma: direct glucose consumption as suggested by (18)F-2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging.

Endocrine 2010 Feb 5;37(1):209-12. Epub 2010 Jan 5.

Department of Endocrine Neoplasia and Hormonal Disorders, Unit 1461, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12020-009-9300-1DOI Listing
February 2010

Peer-reviewed, evidence-based analysis of vitamin D and primary hyperparathyroidism.

World J Surg 2009 Nov;33(11):2292-302

Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, PO Box 301402, Houston, TX 77230-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00268-009-9966-9DOI Listing
November 2009

Skeletal sequelae of cancer and cancer treatment.

J Cancer Surviv 2009 Jun 2;3(2):75-88. Epub 2009 May 2.

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M. D. Anderson Cancer Center, Unit 1461, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11764-009-0083-4DOI Listing
June 2009

Outpatient minimally invasive parathyroidectomy is safe for elderly patients.

J Am Coll Surg 2009 Jun 17;208(6):1071-6. Epub 2009 Apr 17.

Department of Surgery, Eastern Virginia Medical School, Norfolk, VA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jamcollsurg.2009.01.048DOI Listing
June 2009

A novel nomenclature to classify parathyroid adenomas.

World J Surg 2009 Mar;33(3):412-6

Department of Surgical Oncology, Unit 444, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s00268-008-9894
Web Search
http://link.springer.com/10.1007/s00268-008-9894-0
Publisher Site
http://dx.doi.org/10.1007/s00268-008-9894-0DOI Listing
March 2009

Poor survival outcome with moderate and severe hypercalcemia in gynecologic malignancy patients.

Int J Gynecol Cancer 2009 Feb;19(2):178-85

Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-1439, USA.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1111/IGC.0b013e31819c0fd0DOI Listing
February 2009

Preoperative vitamin D replacement therapy in primary hyperparathyroidism: safe and beneficial?

Surgery 2008 Dec;144(6):852-8; discussion 858-9

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Tex, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.surg.2008.06.032DOI Listing
December 2008

Follow-up of pituitary tumor volume in patients with acromegaly treated with pegvisomant in clinical trials.

Eur J Endocrinol 2008 Nov 15;159(5):517-23. Epub 2008 Aug 15.

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/EJE-08-0205DOI Listing
November 2008

Posterior retroperitoneoscopic adrenalectomy: preferred technique for removal of benign tumors and isolated metastases.

Ann Surg 2008 Oct;248(4):666-74

Department of Surgical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0b013e31818a1d2aDOI Listing
October 2008

A novel von Hippel-Lindau point mutation presents as apparently sporadic pheochromocytoma.

Cancer Invest 2008 Jul;26(6):642-6

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1080/0735790070180252
Publisher Site
http://dx.doi.org/10.1080/07357900701802527DOI Listing
July 2008

Management of medullary thyroid carcinoma.

Endocrinol Metab Clin North Am 2008 Jun;37(2):481-96, x-xi

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Unit 435, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ecl.2008.03.001DOI Listing
June 2008

Bone loss in patients with breast or prostate cancer.

Curr Osteoporos Rep 2007 Dec;5(4):170-8

Department of Endocrine Neoplasia, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 435, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
December 2007

Endocrine sequelae of cancer and cancer treatments.

J Cancer Surviv 2007 Dec 20;1(4):261-74. Epub 2007 Nov 20.

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M.D. Anderson Cancer Center, Unit 435, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11764-007-0038-6DOI Listing
December 2007

Review: Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes?

J Clin Endocrinol Metab 2006 Aug 30;91(8):2851-8. Epub 2006 May 30.

Instituto Nacional de Cancerología, Fundación Santafé de Bogotá, Colombia, South America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2005-2178DOI Listing
August 2006

Primary hyperparathyroidism and osteosarcoma: examination of a large cohort identifies three cases of fibroblastic osteosarcoma.

J Bone Miner Res 2005 Sep 9;20(9):1562-8. Epub 2005 May 9.

Department of Endocrinology, Diabetes, and Metabolism, Baylor College of Medicine, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1359/JBMR.050507DOI Listing
September 2005

Vitamin d deficiency and seasonal variation in an adult South Florida population.

J Clin Endocrinol Metab 2005 Mar 5;90(3):1557-62. Epub 2005 Jan 5.

Veterans Affairs Medical Center (11 GRC), 1201 NW 16 Street, Miami, Florida 33125, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2004-0746DOI Listing
March 2005

Graves' disease after interleukin-2 therapy in a patient with human immunodeficiency virus infection.

Thyroid 2004 Dec;14(12):1097-102

Joint Endocrinology, Diabetes & Metabolism Fellowship at Baylor College of Medicine/The University of Texas-M.D. Anderson Cancer Center, Houston 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/thy.2004.14.1097DOI Listing
December 2004

Parathyroid carcinoma: a 22-year experience.

Head Neck 2004 Aug;26(8):716-26

joint Baylor College of Medicine/The University of Texas M. D. Anderson Cancer Center Training Program in Endocrinology, Diabetes, and Metabolism, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.20049DOI Listing
August 2004

Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutation.

J Clin Endocrinol Metab 2004 Aug;89(8):4142-5

The University of Texas MD Anderson Cancer Center, Department of Endocrine Neoplasia and Hormonal Disorders, 1515 Holcombe Boulevard, Unit 435, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2004-0041DOI Listing
August 2004

A novel point mutation of the RET protooncogene involving the second intracellular tyrosine kinase domain in a family with medullary thyroid carcinoma.

J Clin Endocrinol Metab 2004 Jul;89(7):3521-6

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 435, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2004-0073DOI Listing
July 2004

Genetic testing in endocrinology: lessons learned from experience with multiple endocrine neoplasia type 2 (MEN2).

Growth Horm IGF Res 2004 Jun;14 Suppl A:S150-7

Division of Internal Medicine, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M.D. Anderson Cancer Center, Box 433, 1515 Holcombe Blvd., Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ghir.2004.03.033DOI Listing
June 2004